Kensico Capital Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-297,600
Closed -$41.3M 28
2024
Q1
$41.3M Sell
297,600
-4,000
-1% -$503K 1.36% 18
2023
Q4
$37.4M Buy
+301,600
New +$30.8M 1.42% 18

Other funds holding DXCM

Kensico Capital Management's DXCM Position: Q2 2024 in Review

Kensico Capital Management sold out of DexCom (DXCM) in Q2 2024, closing a stake of 297,600 shares — an estimated $41.3M sold.

Kensico Capital Management first reported a position in DXCM in Q4 2023 and held it in 2 quarters. The position peaked at $41.3M in Q1 2024. 1,000 funds tracked by Wall St. Rank hold DXCM as of Q2 2024.

  • Kensico Capital Management reported no remaining DexCom position as of Q2 2024 after selling out during the quarter.
  • Kensico Capital Management sold 297,600 DexCom shares in Q2 2024, an estimated $41.3M.
  • Kensico Capital Management first reported a position in DexCom in Q4 2023 and held it in 2 quarters.
  • Kensico Capital Management's DexCom position peaked at $41.3M in Q1 2024.
  • 1,000 funds tracked by Wall St. Rank held DexCom as of Q2 2024.

Based on Kensico Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.